Physician profile
Jinsong S Wang
NPI 1710966445
$1,196.08
in general payments reported to CMS, 2019-2025
14 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $30.97 · 2021: $94.43 · 2022: $223 · 2023: $149 · 2024: $259 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $275.04 | 2021-2025 | Zilretta, Iovera, Exparel |
| Endo Pharmaceuticals INC. | $226.40 | 2019-2022 | |
| Bioventus LLC | $147.89 | 2023-2025 | Exogen Ultrasound Bone Healing System, Durolane, Durolane |
| Endo USA, INC. | $117.05 | 2024-2025 | Xiaflex |
| Ferring Pharmaceuticals INC. | $103.85 | 2020-2025 | Euflexxa |
| Orthofix Medical, INC. | $63.40 | 2019-2024 | Physio-Stim |
| Amgen INC. | $56.45 | 2023-2025 | Evenity, Prolia |
| Kairos Surgical INC | $39.21 | 2021 | |
| Depuy Synthes Sales INC. | $36.29 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $33.74 | 2024-2025 | |
| Radius Health, INC. | $33.37 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.29 | 2025 | Eohilia |
| Axogen | $19.67 | 2019 | |
| Dynasplint Systems INC. | $19.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinsong Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.